NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.
复制标题

DOI:
10.1016/j.bbmt.2014.12.031
复制
发表时间:
2015-04
影响因子:
4.3
通讯作者:
Kleiner, David E.
Kleiner, David E.
中科院分区:
医学2区
文献类型:
--
作者:
Shulman, Howard M.;Cardona, Diana M.;Greenson, Joel K.;Hingorani, Sangeeta;Horn, Thomas;Huber, Elisabeth;Kreft, Andreas;Longerich, Thomas;Morton, Thomas;Myerson, David;Prieto, Victor G.;Rosenberg, Avi;Treister, Nathaniel;Washington, Kay;Ziemer, Mirjana;Pavletic, Steven Z.;Lee, Stephanie J.;Flowers, Mary E. D.;Schultz, Kirk R.;Jagasia, Madan;Martin, Paul J.;Vogelsang, Georgia B.;Kleiner, David E.

文献摘要

参考文献

被引文献

相似文献

2005年美国国立卫生研究院(NIH)共识会议概述了受急性和慢性移植物抗宿主病(GVHD)影响的主要器官系统的组织病理学诊断标准。2014年共识会议导致了这份更新的文件,其中包括来自肠道,肝脏,皮肤和口腔粘膜中GVHD组织病理学研究的新信息,以及肺和肾脏中GVHD的扩展讨论。最终组织学诊断类别的建议已从4个类别简化为3个类别:无GVHD、可能和可能GVHD,这是基于通过将先前的符合和明确GVHD的类别合并为可能GVHD的单一类别而实现的更好的再现性。在GVHD的组织病理学特征方面仍然存在问题,特别是关于诊断确定性所需的组织学变化的阈值。为将活检信息纳入GVHD的前瞻性临床研究提供了指导,特别是关于生物标志物验证。
The 2005 National Institute of Health (NIH) Consensus Conference outlined histopathological diagnostic criteria for the major organ systems affected by both acute and chronic graft-versus-host disease (GVHD). The 2014 Consensus Conference led to this updated document with new information from histopathological studies of GVHD in the gut, liver, skin and oral mucosa and expanded discussion of GVHD in the lungs and kidneys. The recommendations for final histological diagnostic categories have been simplified from 4 categories to 3: no GVHD, possible, and likely GVHD based on better reproducibility achieved by combining the previous categories of consistent with and definite GVHD into the single category of likely GVHD. Issues remain in the histopathological characterization of GVHD, particularly with respect to the threshold of histological changes required for diagnostic certainty. Guidance is provided for the incorporation of biopsy information into prospective clinical studies of GVHD, particularly with respect to biomarker validation.
DOI: 10.3324/haematol.2011.061051
发表时间: 2012-11-01
期刊: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
影响因子: --
作者:
Andrulis, Mindaugas;Dietrich, Sascha;Luft, Thomas
通讯作者: Luft, Thomas
DOI: 10.1002/lt.20389
发表时间: 2005-05-01
影响因子: 4.6
作者:
Barshes, NR;Myers, GD;Goss, JA
通讯作者: Goss, JA
DOI: 10.1002/mus.21353
发表时间: 2009-10-01
期刊: MUSCLE & NERVE
影响因子: 3.4
作者:
Allen, Jeffrey A.;Greenberg, Steven A.;Amato, Anthony A.
通讯作者: Amato, Anthony A.
DOI: 10.1016/0753-3322(96)82604-7
发表时间: 1995-01-01
影响因子: 7.5
作者:
COOKSLEY, WGE;MCIVOR, CA
通讯作者: MCIVOR, CA
DOI: 10.1016/j.bbmt.2012.09.018
发表时间: 2013-01-01
影响因子: 4.3
作者:
Dietrich, Sascha;Falk, Christine S.;Luft, Thomas
通讯作者: Luft, Thomas